Privacy Policy
Signals Blog

Contributors

Categories

Stacey Johnson

Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.

Posts by: Stacey


Right Turn Special Report: Competition rife in Canada

Author: Stacey Johnson, 12/25/20

(Ed: This blog was originally posted on December 25, 2015. After a difficult year, full of trials and tribulations, reposting this just feels right – even if it is a little dated. Enjoy!) This may come as a shock to many of you, but the land of lakes, trees, socialism and universal healthcare has a […]

Access and affordability of gene therapies at TMM2020

Author: Stacey Johnson, 11/06/20

We heard it first. If you attended the virtual Vancouver version of the 2020 Till & McCulloch Meetings, you had the opportunity to hear from Dr. Janet Rossant, Chair of the Expert Panel on the Approval and Use of Somatic Gene Therapies in Canada, giving us a preview of the “From Research to Reality” report […]

CRISPR gets a Nobel Prize and its own day

Author: Stacey Johnson, 10/20/20

I read somewhere, probably Twitter, that today is World CRISPR Day. I’m willing to play along since now is an excellent time to think about CRISPR. After all, Drs. Emmanuelle Charpentier and Jennifer Doudna received the 2020 Nobel Prize in Chemistry earlier this month for their revolutionary work that has influenced basic, plant and medical […]

Right Turn: Observable progress for people with eye diseases

Author: Stacey Johnson, 10/16/20

The news that Health Canada has approved gene therapy Luxturna to treat blindness couldn’t come at a better time, as October is Blindness Awareness Month. You don’t have to look far to find other high impact research on blindness happening right here in Toronto, Canada. Dr. Molly Shoichet, University of Toronto (UofT), is a world […]

Right Turn: Focusing on EDI to break down barriers in STEM

Author: Stacey Johnson, 10/02/20

In a year during which systemic racism is a talking point and Black Lives Matter is a rallying cry, the ideals of equity, diversity and inclusion (EDI) should be a priority in everyone’s organization. Earlier this week, Centennial College hosted “STEM Reimagined: Fostering Inclusion and Cultivating Success.” The free, online event featured an excellent panel […]